表紙:酢酸ベタメタゾン市場:製剤別、投与経路別、用途別、年齢層別、流通チャネル別、地域別- 規模、シェア、展望、機会分析、2022年~2030年
市場調査レポート
商品コード
1213854

酢酸ベタメタゾン市場:製剤別、投与経路別、用途別、年齢層別、流通チャネル別、地域別- 規模、シェア、展望、機会分析、2022年~2030年

Betamethasone Acetate Market, by Formulation, by Route of Administration, by Application, by Age Group, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 203 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
酢酸ベタメタゾン市場:製剤別、投与経路別、用途別、年齢層別、流通チャネル別、地域別- 規模、シェア、展望、機会分析、2022年~2030年
出版日: 2023年01月12日
発行: Coherent Market Insights
ページ情報: 英文 203 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

ベタメタゾン酢酸エステルは、酢酸エステル、ステロイドエステル、17α-ヒドロキシステロイド、20オキソステロイド、フッ素化ステロイド、11β-ヒドロキシステロイド、3-オキソデルタ(1)、デルタ(4)-ステロイド、3級α-ヒドロキシルケトンです。機能的には、ベタメタゾンと関連しています。

酢酸ベタメタゾンは、長時間作用型のコルチコステロイドで、抗炎症作用と免疫抑制作用があります。自己免疫疾患を含む多くの疾患の治療に非経口的に投与することができ、湿疹を含む炎症性皮膚疾患の治療に局所的に投与することができます。ベタメタゾンリン酸エステルナトリウムおよびベタメタゾン酢酸エステル注射用懸濁液は、骨筋または腱(神経節)の嚢胞性腫瘍にも有用であると考えられます。ベタメタゾン注射用懸濁液は、さまざまな条件による炎症および苦痛を治療するために使用されます。これらの症状には、多発性硬化症、関節炎などが含まれます。

市場力学

酢酸ベタメタゾンは、腎疾患などの様々な病状に使用されるため、腎疾患の有病率の増加が予測期間中の市場成長を促進すると予想されます。例えば、2022年7月、疾病管理予防センター(CDC)が提供するデータによると、2020年には、米国の成人の15%以上、または3700万人が、慢性腎臓病(CKD)を有すると推定されます。また、同資料では、CKDは45~64歳(12%)および18~44歳(6%)よりも65歳以上(38%)でより一般的であるとされています。

酢酸ベタメタは、呼吸器疾患など様々な病状に使用されるため、呼吸器疾患の有病率の増加が予測期間中の酢酸ベタメタの市場成長を促進すると予想されます。例えば、2021年8月、世界保健機関(WHO)によると、2020年約6500万人が中等度から重度の慢性閉塞性肺疾患(COPD)を患っており、世界全体の死亡者数の5%(10万人当たりの死亡者数は41.9人)を占めているそうです。

本調査の主な特徴

  • 本レポートでは、世界の酢酸ベタメタゾン市場を詳細に分析し、2021年を基準年とした予測期間(2022-2030年)の市場規模および年平均成長率(CAGR%)を提示します。
  • 異なるセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案マトリクスを説明します。
  • また、市場促進要因と抑制要因、機会、新製品の発売または承認、市場動向、地域別の展望、主要企業が採用する競合戦略など、重要な考察を提供しています。
  • 以下のパラメータに基づいて、世界の酢酸ベタメタゾン市場の主要企業をプロファイルします- 企業ハイライト、製品ポートフォリオ、主要ハイライト、財務実績、戦略この研究の一部としてカバーされている主要企業にはMerck & Co., Inc., American Regent, Inc., McKesson Medical-Surgical Inc., GNHIndia.com, Lexicon Medical Supply, Medline Industries, Inc., Caspian Tamin Pharmaceutical Co., Sandoz Canada Inc, NorthWestPharmacy.com Inc., Medisca Inc, Exela Pharma Sciences, LLC, Sanofi Pasteur Inc., Sorrento Therapeutics Inc.
  • このレポートからの洞察により、企業のマーケティング担当者や経営陣は、将来の製品発売、タイプアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができるものと思われます。
  • この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
  • 利害関係者は、世界の酢酸ベタメタゾン市場の分析に使用される様々な戦略マトリクスを通じて、意思決定を容易にすることができます。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語の説明

第2章 市場の展望

  • レポート内容
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スナップショット:製剤別
    • 市場スナップショット:投与経路別
    • 市場スナップショット:アプリケーション別
    • 市場スナップショット:年齢層別
    • 市場スナップショット:流通チャネル別
    • 市場スナップショット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場魅力度分析
    • 市場機会
  • 製品上市
  • 合併、買収、共同研究
  • 規制ガイドラインとコンプライアンス
  • 主な発展状況
  • PEST分析
  • 技術情勢
  • PORTERの分析
  • プライシング分析(2021年)

第4章 酢酸ベタメタゾンの世界市場- コロナウイルス(COVID-19)パンデミックの影響

  • 経済的インパクト
  • COVID-19の疫学的特徴
  • 需給への影響

第5章 酢酸ベタメタゾンの世界市場、剤型別、2017年~2030年

  • 懸濁液
  • 軟膏剤
  • ゲル

第6章 酢酸ベタメタゾンの世界市場:投与経路別、2017年~2030年

  • 筋肉内
  • 関節内
  • 皮内

第7章 酢酸ベタメタゾンの世界市場:用途別、2017年~2030年、(米国百万米ドル

  • 呼吸器疾患
  • 腎臓疾患
  • 消化器系疾患
  • 眼科疾患
  • 皮膚科領域
  • その他

第8章 酢酸ベタメタゾンの世界市場:年齢層別、2017年~2030年、(百万米国ドル

  • 小児
  • 老年期

第9章 酢酸ベタメタゾンの世界市場:流通チャネル別、2017年~2030年、(米国百万米ドル)

  • 病院内薬局
  • 小売薬局
  • オンライン薬局

第10章 酢酸ベタメタゾンの世界市場:地域別、2017年~2030年

  • 北米
  • 米国
  • カナダ
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他のラテンアメリカ地域
  • 欧州
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • その他の欧州地域
  • アジア太平洋地域
  • 中国
  • インド
  • 日本
  • ASEAN
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
  • 中東地域
  • GCC
  • イスラエル
  • その他の中東地域
  • アフリカ
  • 北アフリカ
  • 中央アフリカ
  • 南アフリカ

第11章 競合情勢

  • Merck & Co., Inc.
  • American Regent, Inc.
  • McKesson Medical-Surgical Inc.
  • GNHIndia.com
  • Lexicon Medical Supply
  • Medline Industries, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Sandoz Canada Inc.
  • NorthWestPharmacy.com Inc.
  • Medisca Inc.
  • Exela Pharma Sciences, LLC
  • Sanofi Pasteur Inc.
  • Sorrento Therapeutics Inc.

第12章 セクション

  • 調査手法
  • 出版社について
目次
Product Code: CMI5481

Betamethasone acetate is an acetate ester, a steroid ester, a 17alpha-hydroxy steroid, a 20-oxo steroid, a fluorinated steroid, an 11beta-hydroxy steroid, a 3-oxo-Delta (1), Delta (4)-steroid and a tertiary alpha-hydroxyl ketone. It is functionally related to a betamethasone.

Betamethasone acetate is long-acting corticosteroid has anti-inflammatory and immunosuppressive effects. It can be administered parenterally to treat a number of disease states, including autoimmune illnesses, and topically to treat inflammatory skin conditions including eczema. Betamethasone sodium phosphate and betamethasone acetate injectable suspension may also be useful in cystic tumors of an aponeurosis or tendon (ganglia). Betamethasone injectable suspension is used to treat inflammation and pain from a variety of conditions. These conditions include multiple sclerosis, arthritis, and others.

Market Dynamics

The betamethasone acetate is used in various disease conditions such as renal disease, thus the increasing prevalence of renal disease is expected to drive the market growth over the forecast period. For instance, in July 2022, according to data provided by Center of Disease Control and Prevention (CDC), in 2020, more than 15% of the U.S. adults or 37 million people, are estimated to have Chronic Kidney Disease (CKD). Moreover, according to same source CKD is more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%).

The betamethasone acetate is used in various disease condition such as respiratory diseases, thus the increasing prevalence of respiratory disease is expected to drive the betamethasone acetate market growth over the forecast period. For instance, in August 2021, according to the World Health Organization (WHO), in 2020 approximately, 65 million people had moderate to severe Chronic Obstructive Pulmonary Diseases (COPD) that accounts for 5% of deaths (41.9 deaths per 100 000 individuals) globally.

Key features of the study:

  • This report provides in-depth analysis of the global betamethasone acetate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global betamethasone acetate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck & Co., Inc., American Regent, Inc., McKesson Medical-Surgical Inc., GNHIndia.com, Lexicon Medical Supply, Medline Industries, Inc., Caspian Tamin Pharmaceutical Co., Sandoz Canada Inc, NorthWestPharmacy.com Inc., Medisca Inc, Exela Pharma Sciences, LLC, Sanofi Pasteur Inc., Sorrento Therapeutics Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global betamethasone acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global betamethasone acetate market

Detailed Segmentation:

  • Global Betamethasone Acetate Market, By Formulation:
    • Suspension
    • Ointment
    • Gel
  • Global Betamethasone Acetate Market, By Route of Administration:
    • Intramuscular
    • Intra-articular
    • Intradermal
  • Global Betamethasone Acetate Market By Application:
    • Respiratory Disease
    • Renal Disease
    • Gastrointestinal Disease
    • Ophthalmic Disease
    • Dermatological Disease
    • Others
  • Global Betamethasone Acetate Market By Age Group:
    • Pediatric
    • Geriatric
  • Global Betamethasone Acetate Market By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Betamethasone Acetate Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Merck & Co., Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • American Regent, Inc.
    • McKesson Medical-Surgical Inc.
    • GNHIndia .com
    • Lexicon Medical Supply
    • Medline Industries, Inc.
    • Caspian Tamin Pharmaceutical Co.
    • Sandoz Canada Inc
    • NorthWestPharmacy.com Inc.
    • MEDISCA PHARMACEUTIQUE INC
    • Exela Pharma Sciences, LLC
    • Sanofi Pasteur Inc.
    • Sorrento Therapeutics Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Formulation
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Age Group
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • PORTER's Analysis
  • Pricing Analysis (2021)

4. Global Betamethasone Acetate Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Betamethasone Acetate Market, By Formulation, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Ointment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Gel
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Betamethasone Acetate Market, By Route of Administration, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Intra-articular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Intradermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Betamethasone Acetate Market, By Application, 2017 - 2030, (US$ Million

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Renal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Gastrointestinal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Ophthalmic Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Dermatological Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Betamethasone Acetate Market, By Age Group, 2017 - 2030, (US$ Million

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Betamethasone Acetate Market, By Distribution Channel, 2017 - 2030, (US$ Million

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

10. Global Betamethasone Acetate Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Merck & Co., Inc.*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • American Regent, Inc.
  • McKesson Medical-Surgical Inc.
  • GNHIndia.com
  • Lexicon Medical Supply
  • Medline Industries, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Sandoz Canada Inc.
  • NorthWestPharmacy.com Inc.
  • Medisca Inc.
  • Exela Pharma Sciences, LLC
  • Sanofi Pasteur Inc.
  • Sorrento Therapeutics Inc.

12. Section

  • Research Methodology
  • About Us